Arcutis Biotherapeutics (NASDAQ:ARQT) Downgraded by Mizuho
Mizuho cut shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) from a buy rating to a neutral rating in a research report released on Thursday morning, MarketBeat.com reports. ARQT has been the subject of a number of other reports. TD Cowen lowered their price target on Arcutis Biotherapeutics from $65.00 to $50.00 and set an […]
More Stories
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...